Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

We examined estrogen receptor (ER) mRNA expression and molecular subtypes in stage I–III breast cancers that are progesterone receptor (PR) positive but ER and HER2 negative by immunohistochemistry (IHC) or fluorescent in situ hybridization. The ER, PR, and HER2 status was determined by IHC as part...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2014-01, Vol.143 (2), p.403-409
Hauptverfasser:	Itoh, Mitsuya, Iwamoto, Takayuki, Matsuoka, Junji, Nogami, Tomohiro, Motoki, Takayuki, Shien, Tadahiko, Taira, Naruto, Niikura, Naoki, Hayashi, Naoki, Ohtani, Shoichiro, Higaki, Kenji, Fujiwara, Toshiyoshi, Doihara, Hiroyoshi, Symmans, W. Fraser, Pusztai, Lajos
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant treatment Adult Aged Anthracyclines - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biomarkers, Tumor - metabolism Breast cancer Breast Neoplasms - classification Breast Neoplasms - drug therapy Breast Neoplasms - genetics Bridged-Ring Compounds - therapeutic use Brief Report Cancer Cancer research Cancer therapies Criminal investigation Cytogenetics DNA microarrays Endocrine therapy Estrogen Female Gene expression Gene Expression Profiling Hormones Humans Immunohistochemistry Ki-67 Antigen - genetics Medicine Medicine & Public Health Messenger RNA Middle Aged Neoadjuvant Therapy Neoplasm Recurrence, Local - drug therapy Oncology Phenols Receptor, ErbB-2 - metabolism Receptors, Estrogen - genetics Receptors, Estrogen - metabolism Receptors, Progesterone - genetics Receptors, Progesterone - metabolism RNA, Messenger - biosynthesis Survival Rate Taxoids - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!